KITLG and lung cancer: Although FBXO22 was proposed as a specific ubiquitin E3 for SCF-mediated BACH1 degradation in lung cancer cells, experimental evidence for FBXO22-mediated BACH1 ubiquitination in vitro have not yet been obtained (Lignitto et al, 2019).